HomeAARD • NASDAQ
add
Aardvark Therapeutics Inc
Previous close
$8.22
Day range
$7.27 - $8.12
Year range
$4.88 - $19.58
Market cap
172.05M USD
Avg Volume
118.40K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.45M | 323.20% |
Net income | -8.78M | -330.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.44M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 73.66M | 637.44% |
Total assets | 77.51M | 635.64% |
Total liabilities | 5.39M | 276.15% |
Total equity | 72.11M | — |
Shares outstanding | 21.70M | — |
Price to book | -0.61 | — |
Return on assets | -29.30% | — |
Return on capital | -30.61% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -8.78M | -330.13% |
Cash from operations | -7.73M | -568.43% |
Cash from investing | -11.90M | — |
Cash from financing | -1.01M | — |
Net change in cash | -20.64M | -1,685.12% |
Free cash flow | -3.73M | — |
About
Founded
2017
Website
Employees
22
